Status:
COMPLETED
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
Lead Sponsor:
Daiichi Sankyo
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol
Eligibility Criteria
Inclusion
- 18-80 years of age, inclusive;
- A history of primary hypercholesterolemia
Exclusion
- Any serious disorders including pulmonary, hepatic, renal, gastrointestinal (including clinically significant malabsorption), uncontrolled endocrine/ metabolic, hematologic/oncologic (within the last 5 years), neurologic and psychiatric diseases that would interfere with the conduct of the study or interpretation of the data;
- Hepatic dysfunction including biliary cirrhosis, unexplained persistent liver function abnormality, and pre-existing gallbladder disease
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00185107
Start Date
March 1 2005
End Date
October 1 2005
Last Update
September 11 2007
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Clinic
San Diego, California, United States, 92128
2
Renstar Medical Research
Ocala, Florida, United States, 34471
3
Radiant Research
Overland Park, Kansas, United States, 66215
4
L-MARC Research Center
Louisville, Kentucky, United States, 40213